Skip to content

Assessment of the safety and success rate of the mucosal cutting biopsy procedure

Assessment of the safety and success rate of the mucosal cutting biopsy procedure - Assessment of the safety and success rate of the mucosal cutting biopsy procedure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008504
Enrollment
50
Registered
2012-08-01
Start date
2012-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal submucosal tumor

Interventions

mucosal cutting biopsy procedure

Sponsors

Second Department of Internal Medicine, Wakayama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who require the biopsy for gastrointestinal submucosal tumors Under 85 years PS 0-2

Exclusion criteria

Exclusion criteria: Submucosal tumor in the gastrointestinal tract except for esophagus, stomach and colon Patients with bleeding tendency Patients with serious complications(heart disease, liver disease, renal disease ,etc.) Submucosal tumor with extraluminal growth Esophageal submucosal tumor with intramural growth Submucosal tumor with ulcer Patients who cannot undergo endoscopic submucosal dissection Submucosal tumors in the location which is hard to performe regular endoscopic submucosal dissection Patients without written informed consent Patients considered ineligible for this study

Design outcomes

Primary

MeasureTime frame
The success rate of the mucosal cutting biopsy procedure

Countries

Japan

Contacts

Public ContactKosaku Moribata

Second Department of Internal Medicine Second Department of Internal Medicine

073-447-2300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026